SE427274B - Forfarande for framstellning av derivat av 1,2-ditiol-3-tion med verkan mot blodparasiter - Google Patents

Forfarande for framstellning av derivat av 1,2-ditiol-3-tion med verkan mot blodparasiter

Info

Publication number
SE427274B
SE427274B SE7701460A SE7701460A SE427274B SE 427274 B SE427274 B SE 427274B SE 7701460 A SE7701460 A SE 7701460A SE 7701460 A SE7701460 A SE 7701460A SE 427274 B SE427274 B SE 427274B
Authority
SE
Sweden
Prior art keywords
ditiol
tion
procedure
effect
preparing derivatives
Prior art date
Application number
SE7701460A
Other languages
English (en)
Swedish (sv)
Other versions
SE7701460L (sv
Inventor
M Barreau
C Cotrel
C Jeanmart
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7603604A external-priority patent/FR2340730A1/fr
Priority claimed from FR7638901A external-priority patent/FR2374906A2/fr
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of SE7701460L publication Critical patent/SE7701460L/xx
Publication of SE427274B publication Critical patent/SE427274B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
SE7701460A 1976-02-10 1977-02-09 Forfarande for framstellning av derivat av 1,2-ditiol-3-tion med verkan mot blodparasiter SE427274B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7603604A FR2340730A1 (fr) 1976-02-10 1976-02-10 Nouveaux derives du dithiole-1,2, leur preparation et les compositions qui les contiennent
FR7638901A FR2374906A2 (fr) 1976-12-23 1976-12-23 Nouveaux derives du dithiole-1,2, leur preparation et les compositions qui les contiennent

Publications (2)

Publication Number Publication Date
SE7701460L SE7701460L (sv) 1977-08-11
SE427274B true SE427274B (sv) 1983-03-21

Family

ID=26219294

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7701460A SE427274B (sv) 1976-02-10 1977-02-09 Forfarande for framstellning av derivat av 1,2-ditiol-3-tion med verkan mot blodparasiter

Country Status (26)

Country Link
US (1) US4110450A (fr)
JP (1) JPS5822119B2 (fr)
AR (1) AR224095A1 (fr)
AT (1) AT348535B (fr)
AU (1) AU509092B2 (fr)
CA (1) CA1073906A (fr)
CH (2) CH618699A5 (fr)
DE (1) DE2705641C3 (fr)
DK (1) DK55477A (fr)
EG (1) EG13739A (fr)
ES (3) ES455790A1 (fr)
GB (1) GB1518071A (fr)
HK (1) HK17481A (fr)
HU (1) HU172528B (fr)
IE (1) IE44561B1 (fr)
IL (1) IL51403A (fr)
KE (1) KE3126A (fr)
LU (1) LU76728A1 (fr)
MY (1) MY8200001A (fr)
NL (1) NL171985C (fr)
OA (1) OA05565A (fr)
PH (1) PH12367A (fr)
PT (1) PT66175B (fr)
SE (1) SE427274B (fr)
SU (1) SU683622A3 (fr)
ZM (1) ZM1477A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001125A (en) 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
RU2205179C2 (ru) * 1997-10-27 2003-05-27 НьюроСёрч А/С Производное гомопиперазина и фармацевтическая композиция
WO2001085142A1 (fr) 2000-05-05 2001-11-15 Wisconsin Alumni Research Foundation Compositions et methodes permettant de proteger des cellules pendant le traitement du cancer par chimiotherapie et radiotherapie
KR100491318B1 (ko) * 2002-11-26 2005-05-24 씨제이 주식회사 올티프라즈(Ｏｌｔｉｐｒａｚ) 제조방법
AU2005329423A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
WO2006034315A2 (fr) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Derives heterocycliques et utilisation de ceux-ci comme agents therapeutiques
AR051202A1 (es) 2004-09-20 2006-12-27 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
MX2007003321A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
CA2580845A1 (fr) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation en tant qu'agents therapeutiques
CN101083994A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其用作硬脂酰CoA去饱和酶抑制剂的用途
US7951805B2 (en) 2004-09-20 2011-05-31 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
BRPI0611187A2 (pt) 2005-06-03 2010-08-24 Xenon Pharmaceuticals Inc derivados aminotiazàis como inibidores da estearoil-coa desaturase humana
CA2698463A1 (fr) * 2007-08-31 2009-08-06 Cylene Pharmaceuticals, Inc. Modulateurs de kinase therapeutiques
US20160376259A1 (en) * 2015-06-25 2016-12-29 St Ip Holding Ag Methods for Preparing Oltipraz
WO2016207914A2 (fr) * 2015-06-25 2016-12-29 St Ip Holding Ag Procédé de préparation d'oltipraz
WO2018047002A1 (fr) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations de 4-méthyl-5-(pyrazin-2-yl)-3h-1,2-dithiole-3-thione, formulations à goût modifié, et leurs procédés de fabrication et d'utilisation
WO2018047013A1 (fr) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations de 4-méthyl-5-(pyrazine-2-yl)-3 h-1,2-dithiole-3-thione, et leurs procédés de fabrication et d'utilisation
EP3762104A2 (fr) 2018-03-07 2021-01-13 ST IP Holding AG Compositions et thérapies combinées comprenant de la 4-méthyl-5-(pyrazin-2-yl) -3h -1,2-dithiole-3-thione, et procédés de fabrication et d'utilisation associés
US11135220B1 (en) 2020-04-08 2021-10-05 St Ip Holding Ag Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1526768A (fr) 1963-01-16 1968-05-31 Procédé de préparation de dérivés sulfoniques de dithiole-1, 2 thiones-3 diversement substituées, et applications des produits ainsi obtenus

Also Published As

Publication number Publication date
AU2213877A (en) 1978-08-17
ES458688A1 (es) 1978-07-16
CA1073906A (fr) 1980-03-18
ES455790A1 (es) 1978-01-16
HU172528B (hu) 1978-09-28
SE7701460L (sv) 1977-08-11
AR224095A1 (es) 1981-10-30
OA05565A (fr) 1981-04-30
IL51403A (en) 1980-09-16
ZM1477A1 (en) 1977-12-21
JPS5822119B2 (ja) 1983-05-06
NL7701107A (nl) 1977-08-12
KE3126A (en) 1981-05-29
ATA90277A (de) 1978-07-15
DE2705641B2 (de) 1980-05-08
HK17481A (en) 1981-05-08
DE2705641A1 (de) 1977-08-11
IL51403A0 (en) 1977-04-29
MY8200001A (en) 1982-12-31
NL171985C (nl) 1983-06-16
SU683622A3 (ru) 1979-08-30
PT66175B (fr) 1978-07-10
AT348535B (de) 1979-02-26
EG13739A (en) 1983-03-31
CH618699A5 (fr) 1980-08-15
DK55477A (da) 1977-08-11
IE44561B1 (en) 1982-01-13
LU76728A1 (fr) 1977-08-18
ES458689A1 (es) 1978-07-16
PT66175A (fr) 1977-03-01
GB1518071A (en) 1978-07-19
DE2705641C3 (de) 1981-01-22
US4110450A (en) 1978-08-29
PH12367A (en) 1979-01-29
IE44561L (en) 1977-08-10
CH619463A5 (fr) 1980-09-30
JPS52113982A (en) 1977-09-24
AU509092B2 (en) 1980-04-17

Similar Documents

Publication Publication Date Title
SE434395B (sv) Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkan
SE427274B (sv) Forfarande for framstellning av derivat av 1,2-ditiol-3-tion med verkan mot blodparasiter
NO782768L (no) Fremgangsmaate for fremstilling av alkenderivater
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
SE427273B (sv) Forfarande for framstellning av derivat av 1,2-ditiol-3-tion med verkan mot blodparasiter
SE440772B (sv) Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat
SE7808059L (sv) Forfarande for framstellning av 1,2,4-triazin-5-on-derivat
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
SE7704545L (sv) Forfarande for framstellning av nya adeninderivat
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
NO834236L (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater
NO781704L (no) Fremgangsmaate for fremstilling av sesquiterpenderivater
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
SE433220B (sv) Forfarande for framstellning av nya pregnan-derivat
SE440907B (sv) Forfarande for framstellning av imidazolderivat med farmaceutisk verkan
SE437026B (sv) Forfarande for framstellning av bensopyranderivat med antiallergisk verkan
SE431336B (sv) Analogiforfarande for framstellning av substituerade 8-azapurinderivat
NO150087C (no) Fremgangsmaate for fremstilling av cellulosemasse
NO773073L (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
RO77922A (fr) Procede pour la preparation des indoldihydroindol-3-carboxamides dimeres
NO149471C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7603604-5